We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Found that Signals Puberty

By Biotechdaily staff writers
Posted on 04 Nov 2003
Two teams of researchers, working independently, have identified a gene that appears to be a crucial signal for the beginning of puberty in both human beings and mice. More...
In the absence of a functioning copy of this gene, GPR54, neither humans nor mice can normally enter puberty. The findings were reported in the October 23, 2003, issue of The New England Journal of Medicine.

The gene, located on an autosomal chromosome, also appears to be necessary for normal reproductive functioning in humans. Puberty begins when gonadotropin releasing hormone (GnRH) is secreted from the hypothalamus. People who fail to reach puberty because of inherited or spontaneous genetic mutations are infertile. The GPR54 gene contains the information needed to make a receptor. The researchers believe the molecule metastatin binds to this receptor, but they do not know what effect the molecule may have on cells.

The US team included scientists from Massachusetts General Hospital, Brigham and Women's Hospital, and Harvard Medical School (Boston, MA, USA) who collaborated with a researcher at Kuwait University (Safa, Kuwait). The British team included researchers from Pardigm Therapeutics Ltd. and Cambridge University (Cambridge, UK).

"Through some careful detective work, the US researchers pinpointed the gene that causes IHH [idiopathic hypogonadotropic hypogonadism] in this family,” said Louis De Paolo, Ph.D., project officer in the Reproductive Sciences Branch of the US National Institute of Child Health and Human Development (NICHD), which helped to fund the study. "Using the mouse model, the British researchers gained an important insight into the function of the gene.”





Related Links:
Harvard Univ.
Kuwait Univ.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.